maintenance phase is the heavy draw 26 weeks 13 vials Standard Phase 2 duration 32 weeks 16 vials Phase 2 T2D study duration 68 weeks 30 vials REDEFINE 1 / REDEFINE 2 endpoint duration Peptide Vials (10 mg vial, 2.4 mg/week target) Each 10 mg vial covers about 4 weekly doses at 2.4 mg/week
FOXO4-DRI is reported to be sensitive to oxidation and repeated freeze-thaw cycles, so reconstituted material is best used fresh rather than stored for months
J.KimK.SuhS.LeeJ.et al (2022)
When browsing the aisles of your local store, you may notice that there are two distinct types, each of which has notable differences in terms of nutritional value
Summary FOXO4-DRI is a synthetic peptide supplied as a lyophilized powder for controlled laboratory research
Its primary role is to stimulate collagen and elastin production in the dermis, promote antioxidant defenses, and activate genes associated with tissue remodeling and wound repair